48 results
8-K
NDRA
ENDRA Life Sciences Inc
6 Jun 24
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
8:00am
two and one-half years from the Initial Exercise Date.
Pursuant to the common warrants, the Company shall hold a special meeting of stockholders
424B3
NDRA
ENDRA Life Sciences Inc
5 Jun 24
Prospectus supplement
8:20am
by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent … be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum.
Special Meeting of Stockholders. A special
424B5
dx558g0l764guyxhva
3 Apr 24
Prospectus supplement for primary offering
5:15pm
424B5
hlj736yuacvx
3 Apr 24
Prospectus supplement for primary offering
5:14pm
424B5
s800majr
28 Apr 23
Prospectus supplement for primary offering
4:51pm